New Zealand markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
883.33+16.03 (+1.85%)
At close: 04:00PM EDT
885.00 +1.67 (+0.19%)
Pre-market: 05:31AM EDT

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees43,000

Key executives

NameTitlePayExercisedYear born
Mr. David A. RicksChairman, CEO & President6.29MN/A1968
Ms. Anat AshkenaziExecutive VP & CFO2.96MN/A1973
Dr. Daniel M. Skovronsky M.D., Ph.D.EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology3.82MN/A1974
Ms. Anat Hakim J.D.Executive VP, General Counsel & Secretary2.81MN/A1969
Mr. Jacob S. Van NaardenExecutive VP & President of Loxo2.38MN/A1985
Mr. Donald A. ZakrowskiSenior VP of Finance & Chief Accounting OfficerN/AN/AN/A
Mr. Diogo RauEVP & Chief Information and Digital Officer1.06MN/A1975
Mr. Alonzo WeemsEVP of Enterprise Risk Management and Chief Ethics & Compliance OfficerN/AN/A1971
Mr. Eric DozierExecutive Vice President of Human Resources & DiversityN/AN/A1968
Mr. Jeffrey N. SimmonsSenior VP & President of Elanco Animal Health1.73MN/A1967
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Corporate governance

Eli Lilly and Company’s ISS governance QualityScore as of 1 June 2024 is 5. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 9; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.